Boehringer wins accelerated approval for first-line use of lung cancer drug

Lei Lei Wu / endpoints - The FDA greenlit an expanded label for Boehringer Ingelheim’s lung cancer drug Hernexeos, marking the first use of the Commissioner's National Priority Voucher for a new indication. Boehringer won an accelerated

AI Summary: Regulators accelerated approval of Boehringer Ingelheim’s lung cancer therapy for first‑line use, leveraging a priority review mechanism that sped the timeline. The label expansion places the drug into earlier treatment settings, reflecting promising data and the efficiency (and occasional controversy) of voucher‑assisted regulatory pathways.

UHS posts 11.5% operating margin in 2025 as net income jumps 30%

Andrew Cass / beckershospitalreview - King of Prussia, Pa.-based Universal Health Services recorded a net income of $1.5 billion in 2025, up from $1.1 billion in 2024, according to its Feb. 25 financial report. Eight things to know: 1. The for-profit system reported an operating income of $2 …

AI Summary: Universal Health Services reported robust 2025 financial results and outlined an optimistic 2026 outlook, driven by acute and behavioral health operations. Leadership flagged growth targets for admissions and behavioral services even as staffing and regulatory pressures persist — the usual blend of confidence and contingency planning.

Cancer blood test fails to catch disease earlier in major study

medicalxpress - A blood test designed to find cancer early did not work as hoped in a major new study, according to the company that makes it.

AI Summary: A large trial evaluating GRAIL’s multi‑cancer blood screening test failed to meet its primary goal of earlier cancer detection. The disappointing result casts doubt on the test’s clinical utility for population screening, sparks debate over marketing and clinical use, and prompts calls for clearer evidence before widespread adoption.

FDA Launches Framework to Accelerate Individualized Therapies for Ultra-Rare Diseases 2026

oncodaily - The U.S. Food and Drug Administration (FDA) has released groundbreaking draft guidance introducing a new regulatory framework designed to accelerate the development and approval of individualized therapies for patients with […]

AI Summary: The FDA released draft guidance creating a regulatory pathway to speed individualized and N-of-1 cell and gene therapies for ultra‑rare diseases. The framework clarifies evidence expectations, manufacturing and safety-monitoring options, and trial design flexibility to help get bespoke treatments from bench to bedside faster — no miracles promised, just fewer bureaucratic speed bumps.

ChatGPT Health performance in a structured test of triage recommendations

Ashwin Ramaswamy / nature - Nature Medicine, Published online: 23 February 2026; doi:10.1038/s41591-026-04297-7A stress test of ChatGPT Health triage revealed missed high-risk emergencies and inconsistent activation of suicide-crisis safeguards, raising safety concerns for consumer-…

AI Summary: A structured, independent evaluation found that ChatGPT Health—an AI tool offering consumer triage and health guidance—missed or misclassified high-risk cases and gave inconsistent advice. Researchers and clinicians raised safety concerns about relying on the system for urgent medical decision-making, calling for tighter oversight and validation before broad public deployment.

Justice Department sues OhioHealth over alleged anticompetitive insurer contracts

Sydney Halleman / healthcaredive - The DOJ filed a lawsuit last week accusing OhioHealth of leveraging its market power to force insurers to include its providers in their networks.

AI Summary: The Justice Department filed a civil antitrust suit accusing OhioHealth of using its market dominance to force insurers to include all system hospitals in provider networks, allegedly blocking lower‑cost plan options and harming competition. The case seeks to stop contract practices deemed exclusionary and could prompt changes in hospital‑insurer negotiation tactics.

Brain injury is almost ten times more common in unhoused people. Addressing it is key to reducing homelessness

medicalxpress - On any given night, 60,000 people in Canada will go to sleep homeless. Research estimates that more than half of them have had a brain injury at one point in their lives, most of them being injured before becoming homeless. An estimated 22.5% live with mo…

AI Summary: Research indicates people experiencing homelessness suffer brain injuries at dramatically higher rates—approaching a tenfold increase—compared with housed populations. Advocates and clinicians call for routine screening, accessible neurorehabilitation, trauma-informed services and coordinated housing support to address long-term disability and reduce homelessness cycles. The findings argue treating injuries, not just symptoms, yields better social and health outcomes.

FDA formalizes one pivotal trial policy via NEJM perspective

Zachary Brennan / endpoints - Top FDA officials said that a single pivotal trial requirement will be the “new default standard” for drug approvals, a move that goes beyond the agency’s prior discretion around not requiring two trials. In a ...

AI Summary: The FDA has moved to make a single pivotal trial the new default for drug approvals, abandoning the long-standing two-study standard to speed access and ease OTC transitions. The policy, outlined by agency leaders and discussed in a NEJM perspective, raises questions about evidence thresholds and downstream safety monitoring. Welcome to faster approvals — now let's hope that lone study behaves.

Nevada Debuts Public Option Amid Tumultuous Federal Changes to Health Care

Jazmin Orozco Rodriguez / kffhealthnews - The state recently became the third to offer a public option health plan through its Affordable Care Act marketplace. But researchers said it’s unlikely to fill the gaps left by sweeping changes at the federal level.

AI Summary: Nevada has rolled out a public-option plan on its Affordable Care Act marketplace, becoming the third state to do so as federal policy shifts rattle the insurance landscape. Officials tout lower-cost choice for consumers, while researchers warn the move won’t plug major coverage gaps or fully offset the effects of federal changes.

N.I.H. Director Will Temporarily Run C.D.C. in Leadership Shake-Up

Sheryl Gay Stolberg / nytimes - Dr. Jay Bhattacharya will serve as acting director of the Centers for Disease Control and Prevention until President Trump appoints a permanent director.

AI Summary: Dr. Jay Bhattacharya, currently NIH director, has been appointed acting director of the Centers for Disease Control and Prevention, stepping into leadership amid recent departures. He will oversee CDC operations until a permanent nominee is confirmed, inheriting immediate pandemic and preparedness responsibilities — because who doesn’t love an unexpected federal acting role?

As some people push to make profound autism its own diagnosis, this family is raising twins with it

medicalxpress - Connor Murphy walked in circles around his dad, then flopped down on the kitchen floor, got up and walked in circles again.

AI Summary: In a candid portrait, parents caring for twins with severe developmental differences describe daily realities—stereotyped behaviors like pacing and collapse—while advocacy grows to recognize "profound autism" as a distinct diagnosis. Families say a separate label could unlock tailored services and protections, but critics warn of stigma and diagnostic fragmentation; labels aren't magic wands.

Federal judge vacates FTC's expanded premerger notification requirements

fiercehealthcare - The overhaul to the Hart-Scott-Rodino form went into effect in early 2025, and by the regulator's own estimates expanded merging companies' average paperwork burdens from 37 hours to 105 hours. The court's ordered rollback is set to take effect Feb. 19 pe…

AI Summary: A U.S. federal judge vacated the 2025 overhaul of the Hart‑Scott‑Rodino premerger filing rules that had broadened reporting obligations for merging parties. The ruling halts the expanded notification regime, reshaping near‑term M&A compliance expectations and leaving companies—and regulators—scrambling to reassess merger filing practices.

Can medical AI lie? Large study maps how LLMs handle health misinformation

medicalxpress - Medical artificial intelligence (AI) is often described as a way to make patient care safer by helping clinicians manage information. A new study by the Icahn School of Medicine at Mount Sinai and collaborators confronts a critical vulnerability: when a m…

AI Summary: A broad analysis — including Mount Sinai research — shows large language models and medical AI systems can propagate false or misleading health claims when presented in realistic clinical language. Findings expose safety gaps, underline risks of unchecked deployment, and call for tighter guardrails, validation and clinician oversight before clinical use.

Physicians are not 'providers': New paper says names in health care have ethical significance

medicalxpress - A new ethics policy paper from the American College of Physicians (ACP) says the term "provider" should not be used to describe physicians, and using the blanket term undermines physicians' ethical responsibility, clinical integrity, and professionalism.

AI Summary: A new ethics paper contends that referring to doctors as “providers” erodes professional accountability and the ethical obligations central to medicine. Coverage highlights concerns that terminology matters for trust, clinical integrity and patient relationships, prompting debate about language use across health systems and policy forums.

Physicians push back on Alabama robotic ultrasound proposal

Mariah Taylor / beckershospitalreview - Alabama’s proposal to use robotic ultrasounds to close care gaps is being praised by national leaders but facing pushback from local physicians, KFF Health News reported Feb. 12. Alabama is facing above national average rates for infant mortality on top o…

AI Summary: Alabama’s plan to expand robotics in maternity services — including proposals for robotic ultrasounds and other automation — has provoked physician backlash. Clinicians warn that substituting machines for bedside assessment could erode accountability and patient safety in a state already wrestling with poor maternal outcomes, triggering a heated debate about technology versus hands‑on care.

Extracorporeal liver cross-circulation using transgenic xenogeneic pig livers with brain-dead human decedents

Abraham Shaked / nature - Nature Medicine, Published online: 09 February 2026; doi:10.1038/s41591-025-04196-3In a study of four brain-dead human decedents, extracorporeal liver cross-circulation using genetically modified pig livers provides essential hepatic functions, supporting…

AI Summary: In a controversial translational study investigators ran blood between genetically modified pig livers and brain‑dead human decedents using an extracorporeal cross‑circulation system to assess organ viability and function. The work explores a potential bridge to expand transplantable organs, laying technical groundwork while prompting ethical and regulatory questions about next steps.

FDA clears 1st blood test for Alzheimer’s in primary care

Ella Jeffries / beckershospitalreview - The first FDA-cleared blood test to assess Alzheimer’s disease in primary care is now available for patients age 55 and older with symptoms of cognitive decline. The test aims to help clinicians rule out Alzheimer’s by identifying individuals unlikely to …

AI Summary: Regulators cleared the first blood test for Alzheimer’s for primary‑care use while researchers published capillary sampling methods and analyses showing blood biomarkers’ promise for dementia diagnosis. Together these developments push biomarker testing out of specialty clinics and toward routine care — promising earlier detection, though concerns about population diversity, accuracy thresholds and rollout logistics remain.

FDA to reassess the safety of BHA, a preservative used in popular snack foods

go - Federal health officials will reassess the safety of a chemical called BHA used in foods including potato chips, cereals, frozen meals and meat products

AI Summary: U.S. regulators have moved to reevaluate butylated hydroxyanisole (BHA), a common food preservative, ordering a fresh safety review after mounting evidence and public concern. The reassessment could lead to updated guidance or restrictions — which will delight activists and mildly inconvenience snack manufacturers.

Report reveals a significant global palliative care gap among children

medicalxpress - Nearly all the world's 10.6 million children experiencing serious health-related suffering (SHS) live in low- and middle-income countries with little to no access to palliative care or specialized care for their illness, according to a comprehensive new r…

AI Summary: A new global analysis reveals roughly 10.6 million children live with serious health‑related suffering and face a striking lack of pediatric palliative services, especially in low‑ and middle‑income countries. The study calls for urgent policy, training and resource commitments to close the gap and reduce needless pain for sick children — because saying “we’ll do better” is no longer enough.